HAEMONETICS CORP — Director's Dealing 2017

Nov 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-11-14

Reporting Person: Burke Willaim P (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-14	Common Stock	M	11231	$34.21	Acquired	27227	Direct
2017-11-14	Common Stock	S	9909	$54.00	Disposed	17318	Direct
2017-11-14	Common Stock	S	1122	$54.01	Disposed	16196	Direct
2017-11-14	Common Stock	S	100	$54.03	Disposed	16096	Direct
2017-11-14	Common Stock	S	100	$54.04	Disposed	15996	Direct
2017-11-14	Common Stock	S	200	$54.10	Disposed	15796	Direct
2017-11-14	Common Stock	S	200	$54.29	Disposed	15596	Direct
2017-11-14	Common Stock	S	200	$54.15	Disposed	15396	Direct
2017-11-14	Common Stock	S	100	$54.16	Disposed	15296	Direct
2017-11-14	Common Stock	S	100	$54.17	Disposed	15196	Direct
2017-11-14	Common Stock	S	100	$54.19	Disposed	15096	Direct
2017-11-14	Common Stock	S	39	$54.20	Disposed	15057	Direct
2017-11-14	Common Stock	S	161	$54.21	Disposed	14896	Direct
2017-11-14	Common Stock	S	100	$54.233	Disposed	14796	Direct
2017-11-14	Common Stock	S	100	$54.28	Disposed	14696	Direct
2017-11-14	Common Stock	S	200	$54.29	Disposed	14496	Direct
2017-11-14	Common Stock	S	200	$54.31	Disposed	14296	Direct
2017-11-14	Common Stock	S	100	$54.33	Disposed	14196	Direct
2017-11-14	Common Stock	S	162	$54.34	Disposed	14034	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-14	Non-qualified Stock Option (Right to Buy)	$34.21	M	11231	Disposed	2023-10-25	Common Stock (11231)	Direct